The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...
A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
In a 2025 qualitative analysis of payer insights conducted by McKesson and Lumanity, 20 payers representing nearly 280 million covered lives reported that although they broadly view CGTs as safe (90%) ...
Mr Andrews contacted the medical team at Mass General Hospital ( MGH), the hospital in Massachusetts that had carried out the ...
The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.
Lateone monsoon evening in Tiruppur, a textile buyer ran two fingers across a swatch he couldn’t quite place. It felt like ...
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.
ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides ...
Cells contain a blueprint in the form of DNA that dictates what they can make.This blueprint is converted into a message, or mRNA, which is then ...
Medpage Today on MSN
ATTR Trial's Safety Freeze; Heart Failure After Twins; Sotatercept Approval Expands
As alternatives to intravascular lithotripsy, cutting balloon angioplasty and super-high-pressure non-compliant balloons were noninferior in the Short-CUT and VICTORY trials, as highlighted by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results